ES2077144T3 - Composicion farmaceutica que comprende policarbofil calcico. - Google Patents

Composicion farmaceutica que comprende policarbofil calcico.

Info

Publication number
ES2077144T3
ES2077144T3 ES91120102T ES91120102T ES2077144T3 ES 2077144 T3 ES2077144 T3 ES 2077144T3 ES 91120102 T ES91120102 T ES 91120102T ES 91120102 T ES91120102 T ES 91120102T ES 2077144 T3 ES2077144 T3 ES 2077144T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
calcium
polycarbofile
composition including
polycarbophil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120102T
Other languages
English (en)
Inventor
Yasuo Ito
Hideo Kato
Osamu Nagata
Masahiro Yamazaki
Takeo Ishibashi
Masakazu Kitayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2077144T3 publication Critical patent/ES2077144T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN COMPUESTO FARMACEUTICO CAPAZ DE DESINTEGRARSE EN UN MEDIO ACIDO, QUE COMPRENDE CALCIO POLICARBOFILO Y DEL 1 AL 80% DE SU PESO DE UN DERIVADO DE LA CELULOSA TAL COMO LA CARBOXIMETILCELULOSA O UNA HIDROXIPROPILCELULOSA SUSTITUIDA BAJA BASADA EN EL CALCIO POLICARBOFILO. EL COMPUESTO FARMACEUTICO EN FORMA DE TABLETAS, DE CAPSULAS O DE GRANULOS SE UTILIZA COMO UN LAXANTE DE FORMACION DE GRANELES O COMO AGENTE ANTIDIARREICO YA QUE PUEDE DESINTEGRARSE RAPIDAMENTE EN EL ESTOMAGO Y FORMAR UNA DISPERSION COMPLETA DEL POLICARBOFILO EN EL TRACTO DIGESTIVO.
ES91120102T 1990-11-29 1991-11-26 Composicion farmaceutica que comprende policarbofil calcico. Expired - Lifetime ES2077144T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33336890 1990-11-29

Publications (1)

Publication Number Publication Date
ES2077144T3 true ES2077144T3 (es) 1995-11-16

Family

ID=18265330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120102T Expired - Lifetime ES2077144T3 (es) 1990-11-29 1991-11-26 Composicion farmaceutica que comprende policarbofil calcico.

Country Status (7)

Country Link
US (1) US5213806A (es)
EP (1) EP0488139B1 (es)
JP (1) JP2609022B2 (es)
AT (1) ATE125447T1 (es)
CA (1) CA2055905C (es)
DE (1) DE69111574T2 (es)
ES (1) ES2077144T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
ZA937277B (en) * 1992-09-30 1994-05-19 Ascent Pharma Inc Calsium polycarbophil sprinkle
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US6200556B1 (en) * 1996-08-22 2001-03-13 Clive B. Moss High fibre, low calorie, dietary composition
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6248358B1 (en) * 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US8765177B2 (en) 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
WO2001095891A2 (en) * 2000-06-15 2001-12-20 Stockhausen Gmbh & Co. Kg Method for treating dehydration and a composition therefor
TW200404557A (en) * 2002-06-26 2004-04-01 Fuji Yakuhin Co Ltd A pharmaceutical composition for preventive and/or therepeutic treatment of constipation and symptom resulting from constipation
US20050152989A1 (en) * 2003-07-09 2005-07-14 Braintree Laboratories, Inc. Method for treating irritable bowel syndrome
RU2469709C2 (ru) * 2005-11-17 2012-12-20 Новартис Аг Фармацевтическая композиция
TW201010743A (en) * 2008-09-05 2010-03-16 Otsuka Pharma Co Ltd Pharmaceutical solid preparation
CN105012256B (zh) * 2015-07-23 2017-11-14 苏州中化药品工业有限公司 一种用于治疗肠道疾病的药物组合物及其制备方法
CN109562069B (zh) * 2016-04-25 2022-06-03 吉莱斯公司 治疗便秘的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE455561C (de) * 1925-12-29 1928-02-04 Georg Janda Antriebsvorrichtung fuer Motorfahrzeuge mit mehreren Motoren
NL129666C (es) 1962-08-06
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
NZ235876A (en) * 1989-11-01 1992-06-25 Mcneil Ppc Inc Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone
FR2661611B1 (fr) * 1990-05-04 1994-11-18 Theramex Nouvelles compositions pharmaceutiques a base de polycarbophil et leur procede d'obtention.

Also Published As

Publication number Publication date
EP0488139B1 (en) 1995-07-26
ATE125447T1 (de) 1995-08-15
US5213806A (en) 1993-05-25
DE69111574T2 (de) 1996-01-18
EP0488139A1 (en) 1992-06-03
JPH05246861A (ja) 1993-09-24
CA2055905A1 (en) 1992-05-30
JP2609022B2 (ja) 1997-05-14
DE69111574D1 (de) 1995-08-31
CA2055905C (en) 1996-01-30

Similar Documents

Publication Publication Date Title
ES2077144T3 (es) Composicion farmaceutica que comprende policarbofil calcico.
ES2055177T3 (es) Composicion de gemfibrozil con liberacion modificada.
NZ510384A (en) Sustained release ranolazine formulations
EA199800775A1 (ru) Таблетки, содержащие бетта-лактамный антибиотик, и способ их изготовления
ES2097826T3 (es) Matriz de liberacion controlada para composiciones farmaceuticas.
ATE71293T1 (de) Arzneiformulierung.
DE68902344D1 (de) Arzneimittel mit guter stabilitaet.
KR890004686A (ko) 서방성 에토돌락
UA27848C2 (uk) Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну
ATE122880T1 (de) Mehrfach teilbare tablettenstruktur.
KR850700212A (ko) 서방성 약제학적 캼셀제
GB2220855B (en) Use of polymeric compounds in treatment
KR940013347A (ko) 티로신 동물 사료 프리믹스
JPS5781409A (en) External plaster
FR2449686B1 (fr) Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation
EA199800573A1 (ru) Таблетки с высоким содержанием фамцикловира
KR900017584A (ko) 경구용 진해 조성물
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
KR880012206A (ko) 구강질환 치료 조성물
GB1570994A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 488139

Country of ref document: ES